Clinical trial

ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse…

NCT00437775 · Assaf-Harofeh Medical Center, Other · Unknown status

Key facts

NCT number NCT00437775
Title ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects
Official title Angiotensin Converting Enzyme Inhibitors & Angiotensin Receptor Blocker in the Treatment of Type 2 Diabetic Patients Adverse Drug Effects and Drug Interactions- a Survey in an Internal Medicine Department.
Lead sponsor Assaf-Harofeh Medical Center, Other
Status Unknown status
Study type Observational
Conditions Diabetes Mellitus Type 2
Enrollment 300
Start date Jan 1, 2007
Completion Mar 1, 2007
First posted Feb 21, 2007
Last update posted Feb 21, 2007
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies